Psoriaten ointment 50 g #
Category
Psoriasis
Scope of the drug
Leather
Release form
Ointment
Manufacturer country
Germany
Package quantity, pcs
one
Amount in a package
15 g
Dosage form
ointment
Structure
100 g of ointment contain:
active substances: betamethasone dipropionate in terms of betamethasone - 0.05 g, salicylic acid - 3.0 g
excipients: liquid paraffin (liquid paraffin), petrolatum (white vaseline, white soft paraffin).
pharmachologic effect
Combined preparation for external use, the action of which is due to its constituent components
the drug has anti-inflammatory, anti-allergic, antipruritic, keratolytic effects.
Betamethasone inhibits the release of inflammatory mediators, prevents marginal accumulation of neutrophils, reduces inflammatory exudate and cytokine production, reduces the migration of macrophages, leading to a decrease in the processes of infiltration and granulation.
Due to the presence of salicylic acid, it softens the skin, removes horny layers and promotes deeper penetration of betamethasone.
Indications
therapy of subacute and chronic dermatoses, accompanied by hyperkeratosis and desquamation:
- psoriasis
- dyshidrotic dermatitis
- eczema
- neurodermatitis
- lichen planus
- ichthyosis and ichthyosis skin lesions
- atopic dermatitis
- diffuse neurodermatitis
- simple and allergic dermatitis
- urticaria
- exudative erythema multiforme
- simple chronic lichen (limited neurodermatitis)
- dermatoses that cannot be treated with other corticosteroids (especially red warty lichen)
- skin dyshidrosis.
Contraindications
hypersensitivity
open wounds
bacterial, viral and fungal skin diseases (pyoderma, syphilis, skin tuberculosis, chickenpox, herpes, actinomycosis, blastomycosis, sporotrichosis)
post-vaccination skin reactions
perioral dermatitis
rosacea
trophic ulcers against the background of chronic venous insufficiency
skin tumors (skin cancer, nevus, atheroma, epithelioma, melanoma, hemangioma, xanthoma, sarcoma)
lactation period
children under 2 years old.
Carefully
Liver failure
children's age (over 2 years old)
long-term therapy, especially with the use of occlusive dressings.
Side effects
Burning, irritation, dryness, hypopigmentation, itching of the skin, folliculitis, hypertrichosis, dermatitis, acne-like rashes.
When using occlusive dressings - skin maceration, striae, skin atrophy, secondary infection, prickly heat.
With prolonged use - skin atrophy, local hirsutism, telangiectasia, purpura, hypopigmentation, hypertrichosis.
When applied to large surfaces - systemic manifestations of side effects of GCS (growth retardation, Itsenko-Cushing's syndrome, increased ICP after the end of treatment, hyperglycemia, glucosuria, hypokalemia, increased blood pressure) or salicylates (pallor, increased fatigue, drowsiness, hyperventilation against the background of tachypnea, nausea, vomiting, hearing impairment, confusion).
How to take, course of administration and dosage
Outwardly.
Apply to the affected areas at the rate of: a column of ointment 0.5 cm long on a skin area of about 7 × 7 cm, rubbing slightly, with a thin layer, 2 times a day.
A different frequency of use can be established by a doctor, based on the severity of the disease.
In mild cases, it is sufficient to apply the ointment, as a rule, once a day
more severe lesions may require more frequent use.
If necessary, apply occlusive dressings, which are changed every 24 hours.
The duration of treatment depends on the effectiveness and tolerability of therapy and is 2–4 weeks.
If clinical improvement does not occur, the diagnosis must be clarified.
Special patient groups
Children.
Children from 2 years of age are prescribed the drug only on strict indications and under medical supervision, because
possible development of systemic side effects associated with betamethasone.
The duration of treatment should be as short as possible.
When using the drug
Name ENG
REDERM
ATX code
Betamethasone in combination with other drugs
Dosage
0.05% + 3% x 15g
Structure
100 g of ointment contain: active substances: betamethasone dipropionate in terms of betamethasone - 0.05 g, salicylic acid - 3.0 g
excipients: liquid paraffin (liquid paraffin), petrolatum (white vaseline, white soft paraffin).
Indications
Therapy of subacute and chronic dermatoses, accompanied by hyperkeratosis and desquamation:
- psoriasis
- dyshidrotic dermatitis
- eczema
- neurodermatitis
- lichen planus
- ichthyosis and ichthyosis skin lesions
- atopic dermatitis
- diffuse neurodermatitis
- simple and allergic dermatitis
- urticaria
- exudative erythema multiforme
- simple chronic lichen (limited neurodermatitis)
- dermatoses that cannot be treated with other corticosteroids (especially red warty lichen)
- skin dyshidrosis.
Storage conditions and periods
At a temperature not higher than 25 degrees.
Expiration date: 2 years
INN / Active ingredient
betamethasone, salicylic acid
Contraindications
Hypersensitivity
open wounds
bacterial, viral and fungal skin diseases (pyoderma, syphilis, skin tuberculosis, chickenpox, herpes, actinomycosis, blastomycosis, sporotrichosis)
post-vaccination skin reactions
perioral dermatitis
rosacea
trophic ulcers against the background of chronic venous insufficiency
skin tumors (skin cancer, nevus, atheroma, epithelioma, melanoma, hemangioma, xanthoma, sarcoma)
lactation period
children under 2 years old.
Carefully
Liver failure
children's age (over 2 years old)
long-term therapy, especially with the use of occlusive dressings.
Specifications
Category
Acne
Scope of the drug
Leather
Release form
Ointment
Manufacturer country
Russia
Package quantity, pcs
one
Minimum age from
2 years old
Way of introduction
On the skin
Vacation conditions
Without recipe
Brand name
Vertex
The amount of the dosage form in the primary package
15 g
Primary packaging type
Tuba
Type of consumer packaging
Pack of cardboard
Anatomical and therapeutic characteristics
D07XC01 Betamethasone, in combination with other drugs
Dosage form
Ointment for external use
The target audience
Children
Expiration date in days
730
Package weight, g
thirty
Mode of application
:
Outwardly. < br> Apply to the affected areas at the rate of: a column of ointment 0.5 cm long on a skin area of about 7 × 7 cm, rubbing slightly, with a thin layer 2 times a day. A different frequency of use can be established by a doctor, based on the severity of the disease. In mild cases, it is sufficient to apply the ointment, as a rule, once a day more severe lesions may require more frequent use. < br> If necessary, apply occlusive dressings, which are changed every 24 hours. < br> The duration of treatment depends on the effectiveness and tolerability of therapy and is 2-4 weeks. < br> If clinical improvement is not comes, it is necessary to clarify the diagnosis. < br> < br> Special groups of patients < br> Children. Children from 2 years of age are prescribed the drug only under strict indications and under medical supervision, becausepossible development of systemic side effects associated with betamethasone. The duration of treatment should be as short as possible. When using the drug on large surfaces and / or under an occlusive dressing, it is possible to suppress the function of the hypothalamic-pituitary-adrenal system and develop symptoms of hypercortisolism, there may be a decrease in the excretion of growth hormone, an increase in ICP. https://translate.google.com/translate?hl=&sl=ru&tl=en&u=https://zz.buy-pharm.com/xzzakkh.html;Description
Release form, composition and packaging Ointment for external use, homogeneous, light beige
a slight release of oil in the area of the tube opening is possible, which is not a sign of instability and is safe.
10 g
matrix tincture of Mahonia aquifolium D1
1 g
lanolin, lanolin-based alcohol ointment (from lanolin-based alcohols, white petrolatum, cetylstearic alcohol), thick paraffin, purified water.
50 g - aluminum tubes (1) - packs of cardboard. Pharmacological action Homeopathic medicine used in psoriasis.
Mahonia aquifolium (Mahonia podubolistnaya) contains active ingredients, alkaloids, the main of which is berberine.
The drug has an anti-inflammatory effect (due to a decrease in the activity of cyclooxygenase and 5-lipoxygenase enzymes, a violation of the synthesis of arachidonic acid, leukotrienes, prostaglandins, thromboxane, as well as the binding of free radicals) and an antiproliferative effect (due to inhibition of the synthesis of proteins, RNA, DNA, as well as indirect influence on biochemical processes necessary for cell multiplication and synthesis of inflammatory mediators). In addition, berberine is an antagonist of calmodulin, which is involved in the regulation of calcium metabolism in cells and plays an essential role in the processes of cell growth and reproduction. as part of complex therapy).Contraindications to use - hypersensitivity to the components of the drug (for example, to alcohol based on lanolin). Dosage regimen For adults and children over 1 year old, the ointment is applied with a thin layer to the affected areas, rubbing slightly, 3 times / day. not reported Side effects Rarely: allergic skin reactions (to the components of the ointment base) Drug interaction Drug interaction of the drug Psoriaten with other drugs has not been established Use during pregnancy and lactation The use of the drug Psoriaten during pregnancy and lactation (breastfeeding) is possible only if the case when the intended benefit to the mother outweighs the potential risk to the fetus and child.Special instructions When using Psoriaten, a temporary worsening of the condition is possible. In this case, the patient should stop using the drug and consult a doctor.
When using Psoriaten, it is possible to use other drugs.
The patient should be informed that in the absence of a therapeutic effect within 3 weeks, a doctor should be consulted.
Name ENG
PSORIATEN
ATX code
Other drugs for the treatment of psoriasis for external use
Dosage
50g
Structure
Active ingredient: matrix tincture of Mahonia aquifolium (Berberis aquifolium) 10 g
Excipients: lanolin
lanolin alcohol ointment
liquid paraffin
purified water
Indications
treatment of psoriasis and other skin diseases accompanied by dryness and flaking of the skin (as part of complex therapy)
Storage conditions and periods
At a temperature of 0-25 degrees.
Expiration date: 5 years
after opening - 6 months
Contraindications
hypersensitivity to drug components (for example, lanolin-based alcohol)
INN / Active ingredient
matrix tincture of Mahonia aquifolium D1
Specifications
Category
Psoriasis
Scope of the drug
Leather
Release form
Ointment
Manufacturer country
Germany
Package quantity, pcs
one
Minimum age from
1 year
Way of introduction
On the skin
Vacation conditions
Without recipe
Brand name
Deutsche Homoopathie Union
The amount of the dosage form in the primary package
50 g
Primary packaging type
Tuba
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Homeopathic remedy
Dosage form
Ointment for external use
Expiration date in days
1825
The target audience
Children
Dosage (volume) of the substance in the preparation
1 g
Package weight, g
70
Mode of application
:
Locally, for adults and children over 1 year old, apply a thin layer to the affected skin, rubbing slightly, 3 times a day. < br> < br> If there is no therapeutic effect within 3 weeks, you should consult a doctor.
"